Note 3 - Balance Sheet Details (Tables)

6 Months Ended

Jun. 30, 2026

Notes To Financial Statements [Abstract]

Summary of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following (in thousands):


		June 30,				December 31,
		2026				2025
Prepaid insurance		$	687			$	355
Other current receivables			3				264
Prepaid subscriptions and fees			337				145
Prepaid software licenses			59				60
Deferred equity issuance costs			70				—
Prepaid research and development expenses			426				7
Prepaid other			6				5
		$	1,588			$	836

Schedule of Accrued Liabilities

Accrued liabilities consist of the following (in thousands):


		June 30,				December 31,
		2026				2025
Accrued accounts payable		$	173			$	163
Accrued clinical trial expenses			806				801
Accrued chemistry, manufacturing and controls ("CMC") expenses			833				543
Accrued preclinical and translational science expenses			992				188
Accrued director stipends			64				59
Accrued other			268				433
		$	3,136			$	2,187